Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 15, 2024

SELL
$40.25 - $52.99 $13,322 - $17,539
-331 Reduced 1.04%
31,628 $1.31 Million
Q1 2024

May 13, 2024

SELL
$47.98 - $54.4 $239 - $272
-5 Reduced 0.02%
31,959 $1.73 Million
Q4 2023

Feb 08, 2024

BUY
$48.48 - $57.85 $1.55 Million - $1.85 Million
31,964 New
31,964 $1.64 Million
Q4 2022

Feb 09, 2023

SELL
$68.48 - $81.09 $1,438 - $1,702
-21 Reduced 0.68%
3,059 $220,000
Q3 2022

Nov 03, 2022

SELL
$0.13 - $76.84 $2 - $1,383
-18 Reduced 0.58%
3,080 $219,000
Q2 2022

Aug 04, 2022

SELL
$72.62 - $79.98 $6,898 - $7,598
-95 Reduced 2.98%
3,098 $239,000
Q1 2022

May 02, 2022

SELL
$61.48 - $73.72 $16,599 - $19,904
-270 Reduced 7.8%
3,193 $233,000
Q4 2021

Feb 07, 2022

BUY
$53.63 - $62.52 $185,720 - $216,506
3,463 New
3,463 $216,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $124B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Texas Capital Bank Wealth Management Services Inc Portfolio

Follow Texas Capital Bank Wealth Management Services Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Texas Capital Bank Wealth Management Services Inc, based on Form 13F filings with the SEC.

News

Stay updated on Texas Capital Bank Wealth Management Services Inc with notifications on news.